Among the top-ranked hub targets, CYP19A1, aldo-keto reductase (AKR) 1C3, ESR1, AR, and SRD5A2 were identified as key targets via network analysis, indicating their core role in the treatment of POF by Zishen Yutai pills. This evidence concerns the gene SRD5A2 and premature menopause.